Similar articles

• [Prognostic significance of immunologic tests in cancer of the oral cavity].

  Szpirglas H, Castet-Sardjveladzé E, Piadé R, Roth-Ghanassia V, Tsamis J. Szpirglas H, et al. Rev Stomatol Chir Maxillofac. 1977;78(3):207-18. Rev Stomatol Chir Maxillofac. 1977. PMID: 329403 French.
• Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.

  Sprecher-Golberger S, Thiry L, de Halleux F, Bossens M, Gould I. Sprecher-Golberger S, et al. Biomedicine. 1975 Nov 10;23(9):399-401. Biomedicine. 1975. PMID: 182294 No abstract available.
• Cell-mediated and humoral immune responses to primary oral cancers.

  Cannell H. Cannell H. J Maxillofac Surg. 1974 Aug;2(2-3):108-13. doi: 10.1016/s0301-0503(74)80024-x. J Maxillofac Surg. 1974. PMID: 4533015 No abstract available.
• The role of immunology in the diagnosis and treatment of cancer.

  Humphrey LJ, Pierce GE. Humphrey LJ, et al. Prog Clin Cancer. 1975;6:15-36. Prog Clin Cancer. 1975. PMID: 53858 Review. No abstract available.
• Cellular immunity to human tumor-associated antigens. A review.

  Herberman RB. Herberman RB. Isr J Med Sci. 1973 Mar;9(3):300-7. Isr J Med Sci. 1973. PMID: 4575654 Review. No abstract available.